1. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. (February 2022) Authors: Vélez, Iván D; Hien, Tran T; Green, Justin A; Martin, Ana; Sharma, Hema; Rousell, Victoria M; Breton, John J; Ernest, Terry B; Rolfe, Katie; Taylor, Maxine; Mohamed, Khadeeja; Jones, Siôn W; Chau, Nguyen Hoang; Hoa, Nhu Thi; Duparc, Stephan; Tan, Lionel K; Goyal, Navin Journal: Lancet Issue: Volume 6:Number 2(2022) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗